Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system

Area of Science:

• Materials Science
• Polymer Chemistry
• Nanotechnology

Background:

• Biodegradable polymers are crucial for advanced drug delivery systems.
• Developing efficient carriers for chemotherapeutic agents like doxorubicin (DOX) is a key challenge in cancer therapy.

Purpose of the Study:

• To synthesize and characterize a novel biodegradable amphiphilic copolymer for drug delivery.
• To prepare and optimize doxorubicin (DOX)-loaded nanoparticles (NPs) for cancer treatment.
• To evaluate the in vitro anticancer efficacy of the DOX-loaded NPs.

Main Methods:

• Copolymer synthesis involving hydroxypropyl-β-cyclodextrin, polylactide, and a phospholipid.
• Characterization using FT-IR, NMR (1H, 13C, 31P), TGA, and DSC.
• Preparation of DOX-loaded NPs via double emulsion and nanoprecipitation methods.
• In vitro drug release studies and cytotoxicity assays (MTT) on HepG2 and A549 cancer cells.

Main Results:

• Successful synthesis of a novel biodegradable amphiphilic copolymer.
• Optimized NPs achieved a high doxorubicin encapsulation efficiency (EE) of 90.6%.
• In vitro studies demonstrated sustained drug release and potent anticancer activity comparable to free DOX.

Conclusions:

• The novel biodegradable copolymer is a promising platform for developing effective doxorubicin-loaded nanoparticles.
• These NPs exhibit comparable anticancer efficacy to free doxorubicin, suggesting potential for improved cancer therapy.
• Further research into the in vivo performance and therapeutic potential of these nanocarriers is warranted.